The study found that the ADMA concentration was elevated in patients with PAH-CHD compared with patients with CHD alone, while the VEGF expression was significantly higher in patients with persistent PAH and CHD after correction of underlying heart disease than in those with PAH-CHD (77). The gene discussed is VEGFA; the disease is pulmonary arterial hypertension.